[{"NetIncomeLossConverted_1_Q3_USD":-21659000.0,"NetIncomeLossConverted_3_Q3_USD":-56846000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-47257000.0,"CommonStockSharesOutstanding_0_Q3_shares":43128804.0,"StockholdersEquity_0_Q3_USD":272755000.0,"Assets_0_Q3_USD":286100000.0,"CommonStockSharesConverted_0_Q3_shares":43128804.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]